Technical Analysis for CARA - Cara Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 16.13 -5.28% -0.90
CARA closed down 5.28 percent on Thursday, December 5, 2019, on 2.7 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical CARA trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Volume Surge Other -5.28%
Calm After Storm Range Contraction -5.28%

Older signals for CARA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat pain. Its products include intravenous CR845 that has completed Phase II clinical trials for the treatment of acute postoperative pain in adult patients; Oral CR845, which is in Phase I clinical trials to treat acute and chronic pain; and CR701 that is in preclinical trials for treating neuropathic and inflammatory pain. The company was founded in 2004 and is based in Shelton, Connecticut.
Chemistry Health Biopharmaceutical Pain Clinical Trial Piperidines Amines Mesoblast

Is CARA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Indicators
Indicator Value
52 Week High 27.55
52 Week Low 12.19
Average Volume 645,872
200-Day Moving Average 20.70
50-Day Moving Average 20.42
20-Day Moving Average 21.96
10-Day Moving Average 22.43
Average True Range 1.41
ADX 31.88
+DI 20.28
-DI 47.15
Chandelier Exit (Long, 3 ATRs ) 22.44
Chandelier Exit (Short, 3 ATRs ) 20.29
Upper Bollinger Band 27.54
Lower Bollinger Band 16.39
Percent B (%b) -0.02
BandWidth 50.76
MACD Line -0.29
MACD Signal Line 0.56
MACD Histogram -0.8451
Fundamentals Value
Market Cap 525.53 Million
Num Shares 32.6 Million
EPS -2.28
Price-to-Earnings (P/E) Ratio -7.07
Price-to-Sales 424.16
Price-to-Book 3.54
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.62
Resistance 3 (R3) 17.76 17.40 17.37
Resistance 2 (R2) 17.40 17.03 17.33 17.28
Resistance 1 (R1) 16.77 16.79 16.59 16.63 17.20
Pivot Point 16.41 16.41 16.33 16.34 16.41
Support 1 (S1) 15.78 16.04 15.60 15.64 15.06
Support 2 (S2) 15.42 15.80 15.35 14.98
Support 3 (S3) 14.79 15.42 14.89
Support 4 (S4) 14.65